SEARCH

SEARCH BY CITATION

References

  • 1
    James A. Airway remodeling in asthma. Curr Opin Pulm Med 2005;11:16.
  • 2
    Johnson PR, Roth M, Tamm M, Hughes M, Ge Q, King G et al. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001;164:474477.
  • 3
    Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA) 2007. Available at: http://www.ginasthma.org. Accessed 1 July 2008.
  • 4
    Fabel H, Konietzko N. Weißbuch Lunge 2005 – Die Lunge und ihre Erkrankungen: Zur Lage und Zukunft der Pneumologie in Deutschland, 3rd edn. Stuttgart/NewYork: Georg Thieme Verlag KG, 2005.
  • 5
    Stock S, Redaelli M, Luengen M, Wendland G, Civello D, Lauterbach KW. Asthma: prevalence and cost of illness. Eur Respir J 2005;25:4753.
  • 6
    Berdel D, Buhl R, Dierkesmann R, Niebling W, Schultz K, Ukena D. Nationale Versorgungs-Leitlinie Asthma, Kurzfassung, Version 1.4. 2007. Kassenärztliche Bundesvereinigung, Bundesärztekammer, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesesllschaften.
  • 7
    Schramm B, Ehlken B, Smala A, Quednau K, Berger K, Nowak D. Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J 2003;21:116122.
  • 8
    Dietrich ES, Jopp R, Schreier U, Gilge R, Bartmann P, Berthoöd H. Kosten einer leitliniengerechten Arzneimitteltherpie in Deutschland. Gesundh Ökon Qual manag 2005;10:35.
  • 9
    Kolominsky-Rabas PL, Caro JJ. The Hanover Consensus: helpful for German decision-makers? Value Health 2008;11:545546.
  • 10
    Huchon G, Magnussen H, Chuchalin A, Dymek L, Bonnet Gonod F, Bousquet J. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med 2009;103:4149.
  • 11
    Dhillon S, Keating GM. Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler. Drugs 2006;66:14751483.
  • 12
    Rigamonti E, Kottakis I, Pelc M, Grzelewska Rzymowska I, Feschenko Y. Comparison of a new extrafine beclometasone dipropionate HFA 134a-formulated pMDI with a standard BDP CFC pMDI in adults with moderate persistent asthma. Eur Respir J 2006;28(Suppl. 50):P1236.
  • 13
    Busse WW, Brazinsky S, Jacobson K, Stricker W, Schmitt K, Vanden Burgt J et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 1999;104:12151222.
  • 14
    Akazawa M, Stempel DA. Single-inhaler combination therapy for asthma: a review of cost effectiveness. Pharmacoeconomics 2006;24:971988.
  • 15
    Bastian H, Bender R, Ernst AS, Kaiser T, Kirchner H, Kolominsky-Rabas P. IQWIG – Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen – Methoden Version 2.0. 19 December 2006.
  • 16
    Lauer-Fischer GmbH Fürth. Lauer Taxe. 15 July 2008.
  • 17
    Schöffski O, Fricke F-U, Guminski W. Pharmabetriebslehre, 2nd edn. Berlin-Heidelberg: Springer, 2008.
  • 18
    IMS Health GmbH & Co.OHG. R03 Market Sales Data. 31 May 2008.
  • 19
    Kassenärztliche Bundesvereinigung. EBM – Einheitlicher Bewertungsmaßstab. http://www.kbv.de. Accessed 15 July 2008.
  • 20
    Institut für das Entgeltsystem im Krankenhaus – InEK. G-DRG V2005/2007 Report-Browser.
  • 21
    Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D et al. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Health Technol Assess 2008;12:iii360.
  • 22
    Miller E, FitzGerald JM. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies – a Canadian economic evaluation. Can J Clin Pharmacol 2008;15:e165e176.
  • 23
    Rote Liste Service GmbH Frankfurt/Main. Rote Liste – Arzneimittelverzeichnis für Deutschland. http://www.rote-liste.de. Accessed 15 July 2008.
  • 24
    Lyseng-Williamson KA, Plosker GL. Clopidogrel: a pharmacoeconomic review of its use in patients with non-ST elevation acute coronary syndromes. Pharmacoeconomics 2006;24:709726.
  • 25
    Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114:4047.
  • 26
    Horn CR, Clark TJ, Cochrane GM. Compliance with inhaled therapy and morbidity from asthma. Respir Med 1990;84:6770.
  • 27
    Ernst P, McIvor A, Ducharme FM, Boulet LP, FitzGerald M, Chapman KR et al. Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids. Ann Intern Med 2006;145:692694.
  • 28
    Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129:1526.
  • 29
    Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 2006;144:904912.
  • 30
    Brüggenjurgen B, Selim D, Kardos P, Richter K, Vogelmeier C, Roll S et al. Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma. Pharmacoeconomics 2005;23:723731.